Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients

Advanced Drug Delivery Reviews

Volumn 61, Issue 14, 2009, Pages 1343-1352

  Liu, Jiankang ^a,f   Shen, Weili ^b   Zhao, Baolu ^c   Wang, Ying ^d   Wertz, Karin ^d   Weber, Peter ^d   Zhang, Peifang ^e  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

^d DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^e Nestle Beijing R and D Centre   (China)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

( ) Epigallocatechin gallate (EGCG); Acetyl l carnitine; B vitamins; Hydroxytyrosol; Lipoic acid; Mitochondrial nutrients; Reactive oxygen species

Indexed keywords

ACETYL-L-CARNITINE; EPIGALLOCATECHIN GALLATE; HYDROXYTYROSOL; L-CARNITINE; LIPOIC ACIDS; REACTIVE OXYGEN SPECIES;

ACIDS; MITOCHONDRIA; NUTRIENTS; NUTRITION; OXYGEN; VITAMINS;

INSULIN;

2,4 THIAZOLIDINEDIONE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYLCARNITINE; ADIPONECTIN; ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CAFFEINE; CARNITINE; CHOLINE; CREATINE; GLUTATHIONE; INSULIN SENSITIZING AGENT; LEVACECARNINE; MENADIONE; METFORMIN; NICOTINAMIDE; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZING AGENT; PIOGLITAZONE; PYRUVIC ACID; RIBOFLAVIN; SELENIUM; THIAMINE; THIOCTIC ACID; UBIDECARENONE; UBIQUINONE; UNINDEXED DRUG; VITAMIN B GROUP;

BIOGENESIS; BRAIN DISEASE; COMPLEX III DEFICIENCY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG MEGADOSE; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; NUTRITION; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

DIABETES MELLITUS; DIETARY SUPPLEMENTS; DRUG DELIVERY SYSTEMS; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS;

EID: 71849094328     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.06.007     Document Type: Review

References (135)

1. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
2. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., and Shulman G.I. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300 (2003) 1140-1142
3. Mootha V.K., Handschin C., Arlow D., Xie X., St Pierre J., Sihag S., Yang W., Altshuler D., Puigserver P., Patterson N., Willy P.J., Schulman I.G., Heyman R.A., Lander E.S., and Spiegelman B.M. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6570-6575
4. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
5. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
6. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
7. Lamb R.E., and Goldstein B.J. Modulating an oxidative-inflammatory cascade: Potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int. J. Clin. Pract. 62 (2008) 1087-1095
8. Hao J., Shen W., Tian C., Liu Z., Ren J., Luo C., Long J., Sharman E., and Liu J. Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J. Cell. Mol. Med. 13 (2009) 701-711
9. Goldstein B.J., Mahadev K., and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54 (2005) 311-321
10. McClung J.P., Roneker C.A., Mu W., Lisk D.J., Langlais P., Liu F., and Lei X.G. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8852-8857
11. Schulz T.J., Zarse K., Voigt A., Urban N., Birringer M., and Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 6 (2007) 280-293
12. Gomez-Cabrera M.C., Domenech E., Romagnoli M., Arduini A., Borras C., Pallardo F.V., Sastre J., and Vina J. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am. J. Clin. Nutr. 87 (2008) 142-149
13. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
14. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd edition (1999), Oxford University Press, Inc, New York
15. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., Bracale R., Valerio A., Francolini M., Moncada S., and Carruba M.O. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science 299 (2003) 896-899
16. Liu J., and Mori A. Stress, aging, and brain oxidative damage. Neurochem. Res. 24 (1999) 1479-1497
17. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D.C., and Rabinovitch P.S. Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
18. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
19. Fukagawa N.K., Li M., Liang P., Russell J.C., Sobel B.E., and Absher P.M. Aging and high concentrations of glucose potentiate injury to mitochondrial DNA. Free Radic. Biol. Med. 27 (1999) 1437-1443
20. Reznick R.M., and Shulman G.I. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 574 (2006) 33-39
21. Leary S.C., and Shoubridge E.A. Mitochondrial biogenesis: Which part of "NO" do we understand?. Bioessays 25 (2003) 538-541
22. Ruan H., Tang X.D., Chen M.L., Joiner M.L., Sun G., Brot N., Weissbach H., Heinemann S.H., Iverson L., Wu C.F., Hoshi T., and Joiner M.A. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2748-2753
23. Detmer S.A., and Chan D.C. Functions and dysfunctions of mitochondrial dynamics. Nat. Rev., Mol. Cell Biol. 8 (2007) 870-879
24. Anderson D.W., Bradbury K.A., and Schneider J.S. Neuroprotection in Parkinson models varies with toxin administration protocol. Eur. J. Neurosci. 24 (2006) 3174-3182
25. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., and Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160 (2003) 189-200
26. Hood D.A., Irrcher I., Ljubicic V., and Joseph A.M. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Biol. 209 (2006) 2265-2275
27. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., and Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
28. McCarty M.F. Chronic activation of AMP-activated kinase as a strategy for slowing aging. Med. Hypotheses 63 (2004) 334-339
29. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., and Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999) 115-124
30. Semple R.K., Crowley V.C., Sewter C.P., Laudes M., Christodoulides C., Considine R.V., Vidal-Puig A., and O'Rahilly S. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 176-179
31. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int. J. Obes. (Lond) 29 Suppl 2 (2005) S111-115
32. Hoeks J., Hesselink M.K., Russell A.P., Mensink M., Saris W.H., Mensink R.P., and Schrauwen P. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49 (2006) 2419-2426
33. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350 (2004) 664-671
34. Beckman K.B., Saljoughi S., Mashiyama S.T., and Ames B.N. A simpler, more robust method for the analysis of 8-oxoguanine in DNA. Free Radic. Biol. Med. 29 (2000) 357-367
35. Russell A.P. PGC-1alpha and exercise: Important partners in combating insulin resistance. Curr. Diabetes Rev. 1 (2005) 175-181
36. Benton C.R., Wright D.C., and Bonen A. PGC-1alpha-mediated regulation of gene expression and metabolism: Implications for nutrition and exercise prescriptions. Appl. Physiol. Nutr. Metab. 33 (2008) 843-862
37. Earnest C.P. Exercise interval training: An improved stimulus for improving the physiology of pre-diabetes. Med. Hypotheses 71 (2008) 752-761
38. Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., Straubhaar J., Czech M.P., and Corvera S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114 (2004) 1281-1289
39. Bogacka I., Xie H., Bray G.A., and Smith S.R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 (2005) 1392-1399
40. Lameloise N., Muzzin P., Prentki M., and Assimacopoulos-Jeannet F. Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion?. Diabetes 50 (2001) 803-809
41. Kohn A.D., Summers S.A., Birnbaum M.J., and Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271 (1996) 31372-31378
42. Piantadosi C.A., Carraway M.S., Babiker A., and Suliman H.B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103 (2008) 1232-1240
43. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
44. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., and Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009) 1056-1060
45. Koene S., and Smeitink J. Mitochondrial medicine: Entering the era of treatment. J. Intern. Med. 265 (2009) 193-209
46. Reddy P.H. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med 10 (2008) 291-315
47. Armstrong J.S. Mitochondrial medicine: Pharmacological targeting of mitochondria in disease. Br. J. Pharmacol. 151 (2007) 1154-1165
48. Smeitink J.A., Zeviani M., Turnbull D.M., and Jacobs H.T. Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 3 (2006) 9-13
49. Murphy M.P., and Smith R.A. Drug delivery to mitochondria: The key to mitochondrial medicine. Adv. Drug Deliv. Rev. 41 (2000) 235-250
50. Colca J.R. Insulin sensitizers may prevent metabolic inflammation. Biochem. Pharmacol. 72 (2006) 125-131
51. Wilson-Fritch L., Burkart A., Bell G., Mendelson K., Leszyk J., Nicoloro S., Czech M., and Corvera S. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23 (2003) 1085-1094
52. Bogacka I., Ukropcova B., McNeil M., Gimble J.M., and Smith S.R. Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J. Clin. Endocrinol. Metab. 90 (2005) 6650-6656
53. Kukidome D., Nishikawa T., Sonoda K., Imoto K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Matsumura T., and Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55 (2006) 120-127
54. Suwa M., Egashira T., Nakano H., Sasaki H., and Kumagai S. Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J. Appl. Physiol. 101 (2006) 1685-1692
55. Civitarese A.E., Ukropcova B., Carling S., Hulver M., DeFronzo R.A., Mandarino L., Ravussin E., and Smith S.R. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab. 4 (2006) 75-87
56. Liu J., and Ames B.N. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr. Neurosci. 8 (2005) 67-89
57. Liu C.C., Huang C.C., Lin W.T., Hsieh C.C., Huang S.Y., Lin S.J., and Yang S.C. Lycopene supplementation attenuated xanthine oxidase and myeloperoxidase activities in skeletal muscle tissues of rats after exhaustive exercise. Br. J. Nutr. 94 (2005) 595-601
58. Gao X., and Talalay P. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10446-10451
59. Shen W., Hao J., Tian C., Ren J., Yang L., Li X., Luo C., Cotma C.W., and Liu J. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS ONE 3 (2008) e2328
60. Shen W., Liu K., Tian C., Yang L., Li X., Ren J., Packer L., Cotman C.W., and Liu J. R-alpha-Lipoic acid and acetyl-l:- carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 51 (2008) 165-174
61. Echtay K.S. Mitochondrial uncoupling proteins - what is their physiological role?. Free Radic. Biol. Med. 43 (2007) 1351-1371
62. Fridlyand L.E., and Philipson L.H. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8 (2006) 136-145
63. Turanov A.A., Su D., and Gladyshev V.N. Characterization of alternative cytosolic forms and cellular targets of mouse mitochondrial thioredoxin reductase. J. Biol. Chem. 281 (2006) 22953-22963
64. Beck M.A. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. J. Nutr. 127 (1997) 966S-970S
65. Prasad K.N., Cole W.C., and Prasad K.C. Risk factors for Alzheimer's disease: Role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J. Am. Coll. Nutr. 21 (2002) 506-522
66. Marriage B., Clandinin M.T., and Glerum D.M. Nutritional cofactor treatment in mitochondrial disorders. J. Am. Diet. Assoc. 103 (2003) 1029-1038
67. Hongu N., and Sachan D.S. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J. Nutr. 130 (2000) 152-157
68. Hagen T.M., Liu J., Lykkesfeldt J., Wehr C.M., Ingersoll R.T., Vinarsky V., Bartholomew J.C., and Ames B.N. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1870-1875
69. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2356-2361
70. Liu J., Killilea D.W., and Ames B.N. Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-l-carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1876-1881
71. Moini H., Packer L., and Saris N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol. Appl. Pharmacol. 182 (2002) 84-90
72. Packer L., Roy S., and Sen C.K. Alpha-lipoic acid: A metabolic antioxidant and potential redox modulator of transcription. Adv. Pharmacol. 38 (1997) 79-101
73. Packer L., Tritschler H.J., and Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med. 22 (1997) 359-378
74. Packer L., Witt E.H., and Tritschler H.J. alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19 (1995) 227-250
75. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., and Hagen T.M. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3381-3386
76. Cao Z., Tsang M., Zhao H., and Li Y. Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: Protection against oxidative injury. Biochem. Biophys. Res. Commun. 310 (2003) 979-985
77. Jacob S., Streeper R.S., Fogt D.L., Hokama J.Y., Tritschler H.J., Dietze G.J., and Henriksen E.J. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45 (1996) 1024-1029
78. Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schutte K., and Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38 (1995) 1425-1433
79. Ziegler D., and Gries F.A. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46 Suppl 2 (1997) S62-66
80. McCarty M.F. Induction of heat shock proteins may combat insulin resistance. Med. Hypotheses 66 (2006) 527-534
81. Targonsky E.D., Dai F., Koshkin V., Karaman G.T., Gyulkhandanyan A.V., Zhang Y., Chan C.B., and Wheeler M.B. alpha-Lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Diabetologia 49 (2006) 1587-1598
82. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., Yun J.Y., Namgoong I.S., Ha J., Park I.S., Lee I.K., Viollet B., Youn J.H., Lee H.K., and Lee K.U. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 10 (2004) 727-733
83. Cassano P., Sciancalepore A.G., Pesce V., Fluck M., Hoppeler H., Calvani M., Mosconi L., Cantatore P., and Gadaleta M.N. Acetyl-l-carnitine feeding to unloaded rats triggers in soleus muscle the coordinated expression of genes involved in mitochondrial biogenesis. Biochim. Biophys. Acta 1757 (2006) 1421-1428
84. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J. 6 (1992) 3379-3386
85. Costell M., O'Connor J.E., and Grisolia S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem. Biophys. Res. Commun. 161 (1989) 1135-1143
86. Maccari F., Arseni A., Chiodi P., Ramacci M.T., and Angelucci L. Levels of carnitines in brain and other tissues of rats of different ages: Effect of acetyl-l-carnitine administration. Exp. Gerontol. 25 (1990) 127-134
87. Liu J., and Atamna H. Hirohiko Kuratsune, B.N. Ames, Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. N. Y. Acad. Sci. 959 (2002) 133-166
88. Aureli T., Di Cocco M.E., Capuani G., Ricciolini R., Manetti C., Miccheli A., and Conti F. Effect of long-term feeding with acetyl-l-carnitine on the age-related changes in rat brain lipid composition: A study by 31P NMR spectroscopy. Neurochem. Res. 25 (2000) 395-399
89. Ruggiero F.M., Cafagna F., Gadaleta M.N., and Quagliariello E. Effect of aging and acetyl-l-carnitine on the lipid composition of rat plasma and erythrocytes. Biochem. Biophys. Res. Commun. 170 (1990) 621-626
90. Chang T.Y., Chang C.C., Lin S., Yu C., Li B.L., and Miyazaki A. Roles of acyl-coenzyme A: Cholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 12 (2001) 289-296
91. Chang T.Y., Chang C.C., Lu X., and Lin S. Catalysis of ACAT may be completed within the plane of the membrane: A working hypothesis. J. Lipid Res. 42 (2001) 1933-1938
92. Adriaensen H., Plaghki L., Mathieu C., Joffroy A., and Vissers K. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab. Res. Rev. 21 (2005) 231-240
93. Mingrone G. Carnitine in type 2 diabetes. Ann. N. Y. Acad. Sci. 1033 (2004) 99-107
94. Maitra I., Serbinova E., Tritschler H.J., and Packer L. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem. Biophys. Res. Commun. 221 (1996) 422-429
95. Packer L., and Tritschler H.J. Alpha-lipoic acid: The metabolic antioxidant. Free Radic. Biol. Med. 20 (1996) 625-626
96. Head E., Liu J., Hagen T.M., Muggenburg B.A., Milgram N.W., Ames B.N., and Cotman C.W. Oxidative damage increases with age in a canine model of human brain aging. J. Neurochem. 82 (2002) 375-381
97. Ames B.N., and Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann. N. Y. Acad. Sci. 1033 (2004) 108-116
98. Konrad D., Rudich A., Bilan P.J., Patel N., Richardson C., Witters L.A., and Klip A. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 48 (2005) 954-966
99. Alves A.M., Alves E.P., Fregonesi C.E., Defani M.A., Stabille S.R., Evangelista C.C., Dos Santos C.A., and de Miranda Neto M.H. Morphoquantitative aspects of NADH-diaphorase myenteric neurons in the ileum of diabetic rats treated with acetyl-l-carnitine. Anat. Histol. Embryol. 35 (2006) 13-18
100. Sima A.A., Calvani M., Mehra M., and Amato A. Acetyl-l-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 (2005) 89-94
101. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2356-2361
102. Chan C.B., Saleh M.C., Koshkin V., and Wheeler M.B. Uncoupling protein 2 and islet function. Diabetes 53 Suppl 1 (2004) S136-142
103. Shen W., Liu K., Tian C., Yang L., Li X., Ren J., Packer L., Head E., Sharman E., and Liu J. Protective effects of R-alpha-lipoic acid and acetyl-l-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid. J. Cell. Biochem. 104 (2008) 1232-1243
104. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., Yoon Y.S., Yoon G., Choi K.M., and Ko Y.G. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49 (2006) 784-791
105. Shen W., Liu K., Tian C., Yang L., Li X., Ren J., Packer L., Cotman C.W., and Liu J. R-alpha-lipoic acid and acetyl-l-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 51 (2008) 165-174
106. M.C. Price, Longevity report 91: The role of enzymic cofactors in aging. wwwquantiumcwenet/lr91htm#_Toc22709815 (2002).
107. Ames B.N., Elson-Schwab I., and Silver E.A. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am. J. Clin. Nutr. 75 (2002) 616-658
108. Stover P.J. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62 (2004) S3-12 discussion S13.
109. Mock D.M. Marginal biotin deficiency is teratogenic in mice and perhaps humans: A review of biotin deficiency during human pregnancy and effects of biotin deficiency on gene expression and enzyme activities in mouse dam and fetus. J. Nutr. Biochem 16 (2005) 435-437
110. Reaven G.M., Chang H., Ho H., Jeng C.Y., and Hoffman B.B. Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am. J. Physiol. 254 (1988) E23-30
111. Reddi A., DeAngelis B., Frank O., Lasker N., and Baker H. Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice. Life Sci. 42 (1988) 1323-1330
112. Zhang H., Osada K., Maebashi M., Ito M., Komai M., and Furukawa Y. A high biotin diet improves the impaired glucose tolerance of long-term spontaneously hyperglycemic rats with non-insulin-dependent diabetes mellitus. J. Nutr. Sci. Vitaminol. (Tokyo) 42 (1996) 517-526
113. Cui X., Li W., Zhang B., Zhang J., and Ni B. Studies on cell senescence induced by d-galactose in cultured neurons and fibroblasts. Zhongguo Ying Yong Sheng Li Xue Za Zhi 13 (1997) 131-133
114. Vesely D.L. Biotin enhances guanylate cyclase activity. Science 216 (1982) 1329-1330
115. Spence J.T., and Koudelka A.P. Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes. J. Biol. Chem. 259 (1984) 6393-6396
116. Dachicourt N., Bailbe D., Gangnerau M.N., Serradas P., Ravel D., and Portha B. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats. Eur. J. Pharmacol. 361 (1998) 243-251
117. Janssen U., Vassiliadou A., Riley S.G., Phillips A.O., and Floege J. The quest for a model of type II diabetes with nephropathy: The Goto Kakizaki rat. J. Nephrol. 17 (2004) 769-773
118. Palmeira C.M., Ferreira F.M., Santos D.L., Ceica R., Suzuki K., and Santos M.S. Higher efficiency of the liver phosphorylative system in diabetic Goto-Kakizaki (GK) rats. FEBS Lett. 458 (1999) 103-106
119. Moreira P.I., Harris P.L., Zhu X., Santos M.S., Oliveira C.R., Smith M.A., and Perry G. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J. Alzheimer's Dis. 12 (2007) 195-206
120. Harrison W.A. Investigation of the driving experience of a sample of Victorian learner drivers. Accid. Anal. Prev. 36 (2004) 885-891
121. Lee W.J., Song K.H., Koh E.H., Won J.C., Kim H.S., Park H.S., Kim M.S., Kim S.W., Lee K.U., and Park J.Y. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 332 (2005) 885-891
122. Giancaterini A., De Gaetano A., Mingrone G., Gniuli D., Liverani E., Capristo E., and Greco A.V. Acetyl-l-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49 (2000) 704-708
123. McCarty M.F. Up-regulation of PPARgamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. Med. Hypotheses 64 (2005) 399-407
124. Zempleni J., Trusty T.A., and Mock D.M. Lipoic acid reduces the activities of biotin-dependent carboxylases in rat liver. J. Nutr. 127 (1997) 1776-1781
125. Yamanaka M., Itakura Y., Tsuchida A., Nakagawa T., Noguchi H., and Taiji M. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Diabetes Obes. Metab. 9 (2007) 879-888
126. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., and Kim J.B. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006) 2256-2264
127. Tuck K.L., and Hayball P.J. Major phenolic compounds in olive oil: Metabolism and health effects. J. Nutr. Biochem 13 (2002) 636-644
128. Manna C., Galletti P., Cucciolla V., Montedoro G., and Zappia V. Olive oil hydroxytyrosol protects human erythrocytes against oxidative damages. J. Nutr. Biochem 10 (1999) 159-165
129. Stupans I., Kirlich A., Tuck K.L., and Hayball P.J. Comparison of radical scavenging effect, inhibition of microsomal oxygen free radical generation, and serum lipoprotein oxidation of several natural antioxidants. J. Agric. Food Chem. 50 (2002) 2464-2469
130. J. Hao, W. Shen, G. Yu, H. Jia, X. Li, Z. Feng, Y. Wang, P. Weber, K. Wertz, E. Liu, Sharman, J., Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes, J. Nutr. Biochem. 2009 Jul 1. [Electronic publication ahead of print].
131. Higdon J.V., and Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43 (2003) 89-143
132. Moyers S.B., and Kumar N.B. Green tea polyphenols and cancer chemoprevention: Multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 62 (2004) 204-211
133. Mandel S., Weinreb O., Amit T., and Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 88 (2004) 1555-1569
134. Wolfram S., Raederstorff D., Wang Y., Teixeira S.R., Elste V., and Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann. Nutr. Metab. 49 (2005) 54-63
135. Liu J. The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: An overview. Neurochem. Res. 33 (2008) 194-203